141 related articles for article (PubMed ID: 36370473)
1. An optimization study for targeted alpha therapy: Ion behaviours and dose calculations within ICRU-compact bone tissue.
Kara A
Appl Radiat Isot; 2023 Jan; 191():110552. PubMed ID: 36370473
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
Sadremomtaz A; Masoumi M
J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
[TBL] [Abstract][Full Text] [Related]
4. Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.
Hindorf C; Chittenden S; Aksnes AK; Parker C; Flux GD
Nucl Med Commun; 2012 Jul; 33(7):726-32. PubMed ID: 22513884
[TBL] [Abstract][Full Text] [Related]
5. Selection of radionuclide(s) for targeted alpha therapy based on their nuclear decay properties.
Ree SM; Greenwood H; Young JD; Roberts R; Livens FR; Heath SL; Sosabowski JK
Nucl Med Commun; 2024 Jun; 45(6):465-473. PubMed ID: 38465420
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Activity of Novel Bone-seeking, α-emitting
Juzeniene A; Bernoulli J; Suominen M; Halleen J; Larsen RH
Anticancer Res; 2018 Apr; 38(4):1947-1955. PubMed ID: 29599310
[TBL] [Abstract][Full Text] [Related]
7. Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters.
Hamacher KA; Sgouros G
Med Phys; 2001 Sep; 28(9):1857-74. PubMed ID: 11585217
[TBL] [Abstract][Full Text] [Related]
8. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
9. Computational modeling of radiobiological effects in bone metastases for different radionuclides.
Liberal FDCG; Tavares AAS; Tavares JMRS
Int J Radiat Biol; 2017 Jun; 93(6):627-636. PubMed ID: 28276897
[TBL] [Abstract][Full Text] [Related]
10. [Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases].
Heinzer H; König F; Klutmann S
Urologe A; 2014 Apr; 53(4):519-23. PubMed ID: 24604017
[TBL] [Abstract][Full Text] [Related]
11. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
Henriksen G; Breistøl K; Bruland ØS; Fodstad Ø; Larsen RH
Cancer Res; 2002 Jun; 62(11):3120-5. PubMed ID: 12036923
[TBL] [Abstract][Full Text] [Related]
12. Targeted alpha therapy using Radium-223: From physics to biological effects.
Marques IA; Neves AR; Abrantes AM; Pires AS; Tavares-da-Silva E; Figueiredo A; Botelho MF
Cancer Treat Rev; 2018 Jul; 68():47-54. PubMed ID: 29859504
[TBL] [Abstract][Full Text] [Related]
13. Targeted α Therapies for the Treatment of Bone Metastases.
Zustovich F; Barsanti R
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283383
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer.
Parker CC; Pascoe S; Chodacki A; O'Sullivan JM; Germá JR; O'Bryan-Tear CG; Haider T; Hoskin P
Eur Urol; 2013 Feb; 63(2):189-97. PubMed ID: 23000088
[TBL] [Abstract][Full Text] [Related]
15. Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.
; Parker C; Lewington V; Shore N; Kratochwil C; Levy M; Lindén O; Noordzij W; Park J; Saad F
JAMA Oncol; 2018 Dec; 4(12):1765-1772. PubMed ID: 30326033
[TBL] [Abstract][Full Text] [Related]
16. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
Guerra Liberal FD; Tavares AA; Tavares JM
Med Phys; 2014 Nov; 41(11):114101. PubMed ID: 25370676
[TBL] [Abstract][Full Text] [Related]
18. Palliation of Extensive Metastatic Bone Disease With 223Ra-Dichloride α-Particle Therapy in a Patient With Malignant Hereditary Paraganglioma-Pheochromocytoma Syndrome With SDHB Mutation.
Makis W; McCann K; McEwan AJ; Sawyer MB
Clin Nucl Med; 2016 Feb; 41(2):144-7. PubMed ID: 26359562
[TBL] [Abstract][Full Text] [Related]
19. An overview of targeted alpha therapy.
Kim YS; Brechbiel MW
Tumour Biol; 2012 Jun; 33(3):573-90. PubMed ID: 22143940
[TBL] [Abstract][Full Text] [Related]
20. An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT).
Baimukhanova A; Engudar G; Marinov G; Kurakina E; Dadakhanov J; Karaivanov D; Yang H; Ramogida CF; Schaffer P; Magomedbekov EP; Filosofov D; Radchenko V
Nucl Med Biol; 2022; 112-113():35-43. PubMed ID: 35797877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]